Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
BACKGROUND
Calcitonin gene-related peptide (CGRP) may have a causative role in migraine. We therefore hypothesized that a CGRP-receptor antagonist might be effective in the treatment of migraine… Expand
New Appendix Criteria Open for a Broader Concept of Chronic Migraine
- J. Olesen, M. Bousser, +12 authors T. Steiner
- Medicine
- Cephalalgia : an international journal of…
- 1 June 2006
After the introduction of chronic migraine and medication overuse headache as diagnostic entities in The International Classification of Headache Disorders, Second Edition, ICHD-2, it has been shown… Expand
EFNS guidelines on the treatment of cluster headache and other trigeminal‐autonomic cephalalgias
- A. May, M. Leone, +4 authors P. Goadsby
- Medicine
- European journal of neurology
- 1 October 2006
Cluster headache and the other trigeminal‐autonomic cephalalgias [paroxysmal hemicrania, short‐lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT)… Expand
Triptans (Serotonin, 5-HT1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials
- M. Ferrari, P. Goadsby, K. Roon, R. Lipton
- Medicine
- Cephalalgia : an international journal of…
- 1 October 2002
The triptans, selective serotonin 5-HT1B/1D agonists, are very effective acute migraine drugs. Soon, seven different triptans will be clinically available at 13 different oral doses, making… Expand
Cluster headache: A prospective clinical study with diagnostic implications
- A. Bahra, A. May, P. Goadsby
- Medicine
- Neurology
- 12 February 2002
BackgroundCluster headache, when compared with migraine or tension-type headache, is an uncommon form of primary neurovascular headache. However, with a prevalence of approximately 0.1% and a lengthy… Expand
A Controlled Trial of Erenumab for Episodic Migraine
- P. Goadsby, U. Reuter, +7 authors R. Lenz
- Medicine
- The New England journal of medicine
- 24 November 2017
BACKGROUND We tested erenumab, a fully human monoclonal antibody that inhibits the calcitonin gene–related peptide receptor, for the prevention of episodic migraine. METHODS We randomly assigned… Expand
The International Classification of Headache Disorders: 2nd edition
- J. Olesen, P. Goadsby, T. Steiner
- Medicine
- The Lancet Neurology
- 1 December 2003
Pathophysiology of cluster headache: a trigeminal autonomic cephalgia
- P. Goadsby
- Medicine
- The Lancet Neurology
- 1 August 2002
Cluster headache is a form of primary neurovascular headache with the following features: severe unilateral, commonly retro-orbital, pain accompanied by restlessness or agitation, and cranial… Expand
Correlation between structural and functional changes in brain in an idiopathic headache syndrome
- A. May, J. Ashburner, +4 authors P. Goadsby
- Medicine
- Nature Medicine
- 1 July 1999
Fundamental to the concept of idiopathic or primary headache, including migraine, tension-type headache and cluster headache, is the currently accepted view that these conditions are due to abnormal… Expand
EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force
Background: Migraine is one of the most frequent disabling neurological conditions with a major impact on the patients’ quality of life.